AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 04/19/2024
Closing price: 166.41
Support price level: | N/A |
Resistance price level: | $170.40 |
Relative strength index (14-day RSI) | 25.0 |
Beta | 0.48 |
- Volatility is forecast to fall over the next month.
- ABBV is above its 200-day moving average, providing a measure of support for long positions.
- With RSI < 30, ABBV is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$132.51 | $182.10 | 71.7% |
200 day | 50 day | 20 day | 10 day |
$156.04 | $175.24 | $171.68 | $165.83 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
25.3% | 25.9% | 21.8% | 24.3% |
- 5.9% in the next week.
- 13.8% in the next month.
- 38.4% in the next year.
Company news for AbbVie Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks